Trump Strikes Drug Pricing Deals
The White House says nine more drugmakers joined Trump's push to lower prescription costs.
August 31, 2026 · Updated Aug 31, 8:32pm ET
CNBCTrump strikes new drug pricing deals with nine midsized drugmakers
Just the NewsTrump expands Most Favored Nation pricing initiative to drive down drug costs
STAT NewsTrump strikes nine more deals with drugmakers to lower prices
Deseret NewsTrump touts new agreements to lower drug prices
UPITrump touts deals with nine more pharmaceutical companies
Washington TimesMore drugmakers join Trump’s favored-nation pricing plan, bolster his affordability pitch
PoliticoWhite House strikes new drug-pricing deals
Washington ExaminerTrump announces nine most-favored-nation deals to lower drug prices
CBS NewsTrump announces deal with 9 new pharmaceutical firms in move to ease drug costs
New York PostTrump unveils more prescription drug pricing discounts projected to save Americans $600B: ‘Major step forward’
Breitbart NewsTrump Reaches Deals with Nine More Pharmaceutical Companies
One America News NetworkWH announces 9 new agreements with pharma manufacturers aimed at slashing prescription drug costs for Americans
TownhallTrump Provides Key Update With Major Health Care Policy
Epoch TimesTrump Unveils New Drug Pricing Deals With 9 Pharmaceutical Companies
0%
Left · 0
40%
Center · 6
60%
Right · 9
Pano rates the coverage Mostly Right.
What happened
President Donald Trump announced deals with nine more drugmakers—AlconAlconmedical company, Astellas PharmaAstellas Pharmacompany, BeOne MedicinesBeiGenecompany in Cambridge, Massachusetts, USA., BridgeBio, CSLCSL LimitedAustralian biotechnology company, Kyowa Kirin, Sun Pharma, Teva Pharmaceuticals and UCB—to cut prices under his most-favored-nation initiative. The White House said the additions bring the program to 26 companies covering 89% of the branded drug market. The voluntary agreements target discounted sales to state Medicaid programs and tie U.S. prices to the lowest prices paid in other developed countries. Trump projected more than $600 billion in savings, though drug-by-drug prices and discount terms have not been released.
